Study: Protein disruption linked to blood cancers

10/15/2008 | United Press International

A study by Stanford University School of Medicine researchers is the first to directly associate the retinoblastoma family of proteins to blood and immune cell production. Interrupting the function of the molecules leads to a proliferation of certain cells, similar to those that occur in several human blood cancers.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ